Publications by authors named "Shi-Hang Zheng"
Introduction: Colorectal cancer has been ranked third among the most common cancers worldwide and raised to the second leading cause of cancer death with nearly one-tenth of cancer-related deaths globally, and nearly half of colorectal cancer patients present with or develop colorectal cancer liver metastasis (CRLM). Buzhong Tiaogan Formula (BTF) has been proven to treat CRLM in our team, but there are lacking of evidence on its effective in delaying colorectal liver metastasis (liver depression spleen deficiency type), so we will evaluate the efficacy and safety of BTF in preventing the occurrence of CRLM.
Methods: This randomized controlled trial (RCT) will be carried out in 3 different hospitals in Shanxi Province planning to recruit 150 CRLM patients with the type of liver depression spleen deficiency.
Article Synopsis
- Colorectal cancer (CRC) is a major health threat, being the fourth most common cancer in males and third in females, with advanced cases often requiring chemotherapy that has significant side effects.
- This study will evaluate the effectiveness and safety of the modified GGQL formula, used alongside traditional cancer treatments, for advanced CRC patients experiencing symptoms related to damp-heat.
- A multicenter randomized controlled trial (RCT) will be conducted with 120 patients to measure outcomes like quality of life and tumor status, aiming to provide insights into the role of Chinese herbal medicine in CRC treatment.